Search Results - "Demirdogen, E"

436 Evaluating of BRCA1 and BRCA2 Germ-line Mutations and BRCA Risk Assessment of Mutation Carriers in Turkish Breast Cancer Patients by Cecener, G, Egeli, U, Tunca, B, Erturk, E, Gokgoz, S, Tasdelen, I, Ak, S, Demirdogen, E, Tezcan, G, Bayram, N

Get full text

Novel benzoylthiourea derivatives had differential anti-inflammatory photodynamic therapy potentials on in vitro stimulated mammalian macrophages by Emen, Fatih M., Kutlu, Emine, Karacolak, Ali I., Ali, Muhammad A., Demirdogen, Ruken E., Yesilkaynak, Tuncay, Erat, Selma, Ayaz, Furkan

“…•Different thiourea derivatives with PDT potentials were synthesized.•They all lacked anti-inflammatory activity in dark conditions.•Only one of them exerted…”
Get full text

Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy by Acet-Öztürk, NA, Ömer-Topçu, D, Vurat-Acar, K, Aydın-Güçlü, Ö, Pınar, İE, Demirdöğen, E, Görek-Dilektaşlı, A, Kazak, E, Özkocaman, V, Ursavas, A, Akalın, H, Özkalemkaş, F, Ener, B, Ali, R

“…The first consensus definitions for invasive fungal diseases (IFD) were published in 2002. Advances in diagnostic tests and a clear need for improvement in…”
Get full text

SUN-P152: Nutritional Assessment of In-Patient Respiratory Care Patients by Görek Dilektaşlı, A, Demirdogen Cetinoglu, E, Acet, N.A, Sakarya, M, Coskun, F, Ursavas, A, Karadag, M, Uzaslan, E

Get full text

SUN-P194: Conservative Treatment of Chylothorax During Pregnancy by Görek Dilektaşlı, A, Aydın Güçlü, Ö, Demirdogen Cetinoglu, E, Acet Ozturk, N, Ursavas, A, Erdogan, C, Karadag, M, Uzaslan, E

Get full text

B104 TICKET TO RIDE: MOVING FORWARD WITH SARCOIDOSIS EVALUATION AND TREATMENT: Association Of Fatigue With Mental Well-Being, Quality Of Life And Exercise Capacity In Sarcoidosis: A Case-Control Comparision by Dilektasli, A Gorek, Cetinoglu, E Demirdogen, Acet, N A, Gokmen, N E, Karadag, M, Uzaslan, E

Get full text

B34 ALL THINGS MUST PASS: COPD EXACERBATIONS: Clinical, Functional Characteristics And Exercise Capacity Of The Frequent Exacerbator COPD Phenotype by Uzaslan, E, Dilektasli, A Gorek, Cetinoglu, E Demirdogen, Budak, F, Coskun, F, Ursavas, A, Ege, E

Get full text

D44 COPD: TREATMENT FROM BRONCHODILATORS TO OTHER PHARMACOLOGICAL INTERVENTIONS: How Ageing Effects Hospitalization In Patients With Acute Exacerbation Of Chronic Obstructive Pulmonary Disease? by Uzaslan, E, Dilektasli, A Gorek, Cetinoglu, E Demirdogen, Coskun, F, Ozkaya, G, Ege, E

Get full text

C25 THUNDERBALL: SPEEDING FORWARD OUR UNDERSTANDING OF SARCOIDOSIS: Clinical Course And Diagnostic Work-Up Of Sarcoidosis: Retrospective Analysis Of A 10-Year Experience by Dilektasli, A Gorek, Cetinoglu, E Demirdogen, Coskun, F, Ursavas, A, Uzaslan, E

Get full text

Luminescent core–shell Ca2MoO5:Eu3+-MCM-41 structure for sustained drug release by Karacolak, A.I., Emen, F.M., Kılıç, D., Kutlu, E., Ali, M.A., Körözlü, N., Demirdogen, R.E.

“…The spherical mesoporous MCM-41 coated with a novel Ca2MoO5:Eu3+ phosphor layer was prepared for the first time. The obtained Ca2MoO5:Eu3+-MCM-41 was…”
Get full text

P224 Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey by Erdal, M. Akgül, Büyükşahin, H. Nayır, Şen, V., Kılınç, A. Ayzıt, Çokuğraş, H., Demir, A. Doğan, Doğan, G., Yılmaz, A.İ., Ünal, G., Serbes, M., Altıntaş, D.U., Keskin, Ö., Özaslan, M.M., Karcıoğlu, O., Köse, M., Basaran, A.E., Çakır, E.P., Canıtez, Y., Özdemir, A., Harmancı, K., Uytun, S., Polat, S. Eryılmaz, Hangül, M., Yüksel, H., Özcan, G., Korkmaz, P., Kiliç, M., Aydın, Z.G. Gayretli, Çaltepe, G., Can, D., Doğru, S., Öztürk, G. Kartal, Süleyman, A., Topal, E., Özsezen, B., Hızal, M., Demirdöğen, E., Ogun, H., Börekçi, Ş., Yazan, H., Şen, H. Selimoğlu, Çakır, E., Eyüboğlu, T. Şişmanlar, Emiralioğlu, N., Pekcan, S., Özçelik, U., Doğru, D.

Get full text

Response to "Hypercapnic respiratory failure with insufficient response to fixedlevel PS-NIV: Is AVAPS the end solution?" by Acet Öztürk, Nilüfer Aylin, Aydın Güçlü, Özge, Demirdöğen, Ezgi, Görek Dilektaşlı, Aslı, Maharramov, Shahriyar, Coşkun, Funda, Uzaslan, Esra, Ursavaş, Ahmet, Karadağ, Mehmet

Get full text

Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization by Dilektasli, Asli Gorek, Demirdogen Cetinoglu, Ezgi, Uzaslan, Esra, Budak, Ferah, Coskun, Funda, Ursavas, Ahmet, Ercan, Ilker, Ege, Ercument

“…Chemokine (C-C motif) ligand 18 (CCL-18) has been shown to be elevated in chronic obstructive pulmonary disease (COPD) patients. This study primarily aimed to…”
Get full text